Evaluation of Serum Posaconazole Concentrations in Patients with Hematological Malignancies Receiving Posaconazole Suspension Compared to the Delayed-Release Tablet Formulation

Figure 1

Linear regression model of posaconazole concentrations stratified by mucositis and treatment group. PCZ-tab group was significantly decreased by presence of mucositis, whereas no effect was seen in the PCZ-susp group.